Literature DB >> 16478471

Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores.

Ana J García-Sáez1, Manuela Coraiola, Mauro Dalla Serra, Ismael Mingarro, Peter Müller, Jesús Salgado.   

Abstract

Proteins of the B-cell lymphoma protein 2 (Bcl2) family are key regulators of the apoptotic cascade, controlling the release of apoptotic factors from the mitochondrial intermembrane space. A helical hairpin found in the core of water-soluble folds of these proteins has been reported to be the pore-forming domain. Here we show that peptides including any of the two alpha-helix fragments of the hairpin of Bcl2 associated protein X (Bax) can independently induce release of large labelled dextrans from synthetic lipid vesicles. The permeability promoted by these peptides is influenced by intrinsic monolayer curvature and accompanied by fast transbilayer redistribution of lipids, supporting a toroidal pore mechanism as in the case of the full-length protein. However, compared with the pores made by complete Bax, the pores made by the Bax peptides are smaller and do not need the concerted action of tBid. These data indicate that the sequences of both fragments of the hairpin contain the principal physicochemical requirements for pore formation, showing a parallel between the permeabilization mechanism of a complex regulated protein system, such as Bax, and the much simpler pore-forming antibiotic peptides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478471     DOI: 10.1111/j.1742-4658.2006.05123.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  47 in total

1.  Pores formed by Baxα5 relax to a smaller size and keep at equilibrium.

Authors:  Gustavo Fuertes; Ana J García-Sáez; Santi Esteban-Martín; Diana Giménez; Orlando L Sánchez-Muñoz; Petra Schwille; Jesús Salgado
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

2.  All-or-none versus graded: single-vesicle analysis reveals lipid composition effects on membrane permeabilization.

Authors:  Beatriz Apellániz; José L Nieva; Petra Schwille; Ana J García-Sáez
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

Review 3.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Rational development of a cytotoxic peptide to trigger cell death.

Authors:  Rebecca J Boohaker; Ge Zhang; Michael W Lee; Kathleen N Nemec; Santimukul Santra; J Manuel Perez; Annette R Khaled
Journal:  Mol Pharm       Date:  2012-05-29       Impact factor: 4.939

5.  Monte Carlo simulations of tBid association with the mitochondrial outer membrane.

Authors:  Valery G Veresov; Alexander I Davidovskii
Journal:  Eur Biophys J       Date:  2007-03-21       Impact factor: 1.733

6.  Pore formation by a Bax-derived peptide: effect on the line tension of the membrane probed by AFM.

Authors:  Ana J García-Sáez; Salvatore Chiantia; Jesús Salgado; Petra Schwille
Journal:  Biophys J       Date:  2007-04-06       Impact factor: 4.033

7.  Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores.

Authors:  Shuo Qian; Wangchen Wang; Lin Yang; Huey W Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

Review 8.  The rheostat in the membrane: BCL-2 family proteins and apoptosis.

Authors:  N Volkmann; F M Marassi; D D Newmeyer; D Hanein
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

Review 9.  Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.

Authors:  D Westphal; R M Kluck; G Dewson
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

10.  Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model.

Authors:  Anastassia Karageorgis; Michaël Claron; Romain Jugé; Caroline Aspord; Fabien Thoreau; Claire Leloup; Jérôme Kucharczak; Joël Plumas; Maxime Henry; Amandine Hurbin; Pascal Verdié; Jean Martinez; Gilles Subra; Pascal Dumy; Didier Boturyn; Abdel Aouacheria; Jean-Luc Coll
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.